8-KThe WireRed Alert
Executive Change
Filed May 5, 2026 · 1mo ago · Accession 0001193125-26-206315
Plain English
DBV Technologies S.A. approved the 2026 Performance Share Unit Plan and granted 1,740,000 performance share units to its CEO, Daniel Tassé, on April 30, 2026. The vesting of these units is contingent on FDA acceptance for review of Viaskin Peanut biologics license applications and continued employment.
Filing details
- Company
- DBV Technologies S.A.
- Ticker
- DBVT
- CIK
- 1613780
- Form type
- 8-K
- Filing date
- May 5, 2026
- Report date
- Apr 30, 2026
- Document
- d150727d8k.htm
- Size
- 190 KB